2023-01-26: On January 24, Zhongsheng Pharmaceutical said on the interactive platform that the company is continuing to promote the non-public offering of A-shares. The company has received the Notice of Second Feedback Opinions on the Review of Administrative Licensing Projects by the China Securities Regulatory